A potential partner will look past your topline data to how the trial was run. Partnering-ready clinical operations mean an inspection-ready trial master file, clean and well-documented data, clear vendor oversight records, transparent handling of deviations and safety, contracts that can be assigned or transferred and a team that can answer questions quickly and consistently. The time to prepare is months before the first diligence request, not the week the data room opens.
What do partners look for in clinical operations?
Evidence that the data can be trusted and will support regulatory submissions. They review how the study was designed and conducted, how quality was managed, how vendors were overseen and whether there are issues that could delay or derail development. They also want to understand what it would take to continue or expand the program, including contracts, supply and site relationships.
Which documents will they request?
Protocols, amendments and their rationale.
The trial master file, or a structured index of it.
Monitoring, quality and audit reports, including findings and CAPAs.
Deviation logs and how important deviations were handled.
Safety data and reporting history.
Vendor contracts and oversight records.
Data management plans, statistical analysis plans and data standards.
Regulatory correspondence and meeting minutes.
What red flags slow or sink deals?
An incomplete or disorganized trial master file. Unresolved audit or inspection findings. Inconsistent deviation handling. Data that cannot be traced or converted to submission standards. Contracts that cannot be assigned or that restrict data use. Unclear ownership of data or intellectual property generated by vendors. Key knowledge held only by one person who may leave.
How should you prepare?
Run a mock diligence review of your clinical operations, ideally by someone independent of the study team. Fix gaps in the trial master file and documentation. Close open CAPAs and document their effectiveness. Confirm data standards and traceability. Review contracts for assignment, data rights and transition clauses. And prepare concise summaries of the study's conduct, quality management and key issues, with honest explanations.
How should you handle known issues?
Disclose them proactively with context and the actions taken. Partners expect some issues; every study has them. What erodes trust is discovering a problem the company didn't mention or didn't understand. A clear account of what happened, why and how it was addressed often turns a potential red flag into evidence of good management.
Who should be involved?
Clinical operations, quality, regulatory, data management and biostatistics, with business development coordinating. Agree in advance who answers which questions and how responses are reviewed. Consistency matters: conflicting answers from different people create doubt.
How does this connect to financing?
The same preparation supports investor diligence, an acquisition or a regulatory inspection. Building partnering readiness into normal operations, rather than treating it as a project, makes the company stronger in every scenario.
Keep reading: Matching Clinical Milestones to Your Runway
